GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal
GSK’s presence in immunology and inflammation is heavily oriented around respiratory drugs, but the company has been expanding its scope...
Grows
GSK’s presence in immunology and inflammation is heavily oriented around respiratory drugs, but the company has been expanding its scope...
